Articles - Page 69 of 96 - Drugs in Context

Gastroesophageal reflux in children: an updated review

Alexander KC Leung MBBS, FRCPC, FRCP (UK and Irel), FRCPCH, FAAP, Kam Lun Hon MD, FAAP, FCCM

Article Type

Review

Published

17 Jun 2019

This review article provides an update on the current understanding, evaluation, and management of gastroesophageal reflux in children.

Immunotherapy in inoperable stage III non-small cell lung cancer: a review

Natasha A Jain MD, Gregory A Otterson MD

Article Type

Review

Published

17 Jun 2019

This article summarizes the current status and ongoing clinical trials incorporating immunotherapy into the management of inoperable stage III nonsmall cell lung cancer.

Use of botulinum toxin for movement disorders

Carlos Henrique Ferreira Camargo MD, MSc, PhD, Hélio Afonso Ghizoni Teive MD, MSc, PhD

Article Type

Review

Published

18 Jun 2019

The aim of this review is to present the new and well-established uses of botulinum toxin for movement disorders.

Easyhaler®: an overview of an inhaler device for day-to-day use in patients with asthma and chronic obstructive pulmonary disease

Federico Lavorini MD, PhD

Article Type

Review

Published

05 Jun 2019

The aim of this article is to provide an overview of the scientific literature on Easyhaler, with the purpose of emphasising features that make it close to the concept of an ‘ideal’ inhaler for daily use in patients with asthma or chronic obstructive pulmonary disease.

Efficacy and safety of lesinurad for the treatment of hyperuricemia in gout

Fernando Pérez-Ruiz MD, PhD, Tim Jansen MD, Anne-Katrin Tausche MD, Mónica Juárez-Campo BSc, Ravichandra Karra Gurunath MD, Pascal Richette MD, PhD

Article Type

Review

Published

15 May 2019

The review aims to review current evidence about the efficacy and safety of lesinurad in combination with xanthine oxidase inhibitors in the treatment of hyperuricemia in patients with gout.